NORSPAN

This brand name is authorized in Austria, Australia, Germany, Ecuador, Estonia, Finland, Hong Kong, Japan, Lithuania, New Zealand

Active ingredients

The drug NORSPAN contains one active pharmaceutical ingredient (API):

1 Buprenorphine
UNII 40D3SCR4GZ - BUPRENORPHINE

Buprenorphine is an opioid partial agonist/antagonist which attaches itself to the μ (mu) and κ (kappa) receptors of the brain. Its activity in opioid maintenance treatment is attributed to its slowly reversible link with the μ receptors which, over a prolonged period, minimises the need of illicit opioids for patients with opioid dependence.

Read about Buprenorphine

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
NORSPAN Patch Medicines and Medical Devices Safety Authority (NZ) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
N02AE01 Buprenorphine N Nervous system → N02 Analgesics → N02A Opioids → N02AE Oripavine derivatives
Discover more medicines within N02AE01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: AU Pharmaceutical Benefits Scheme Identifier(s): 10746N, 10755C, 10756D, 10770W, 10948F, 10949G, 10953L, 10957Q, 10959T, 10964C, 10970J, 8865N, 8866P, 8867Q
Country: DE Bundesinstitut für Arzneimittel und Medizinprodukte Identifier(s): 00683602, 00683619, 00683660, 00684317, 00684346, 00684352, 03323258, 03323264, 03323287, 10005843, 10005866, 10005872, 10179684, 10179690, 10179709, 10179715, 10179721, 10179738, 10179744, 10179750, 10179767, 10226099, 10226107, 10226113, 10226136, 10226142, 10226159, 10226165, 10226171, 10226188, 11525467, 11525473, 11525496, 11525504, 11525510, 11525527, 16003555, 16003561, 17532994, 17533002, 17533019, 17533025, 17533031
Country: EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria Identifier(s): 1648-MEE-0116, 1788-MEE-0216, 2244-MEE-0616
Country: EE Ravimiamet Identifier(s): 1305885, 1305908, 1305919, 1305920, 1305931, 1305942, 1305953, 1305964, 1305975, 1305986, 1305997, 1306000, 1306011, 1306022, 1306033, 1306044, 1306055, 1306066, 1306077, 1306088, 1306099, 1306101, 1306112, 1306123
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 068046, 068112, 149386, 149397, 149408, 183264, 433624, 456128
Country: HK Department of Health Drug Office Identifier(s): 61495, 61496, 61497
Country: JP 医薬品医療機器総合機構 Identifier(s): 1149704S1020, 1149704S2027, 1149704S3023
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1026205, 1026206, 1026207, 1033071, 1033072, 1033073, 1033074, 1033075, 1033076, 1033077, 1033078, 1033079, 1033080, 1033081, 1033082, 1033083, 1033084, 1033085, 1033086, 1033087, 1033088, 1033089, 1033090, 1033091
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 12436, 12437, 12438

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.